Outset Medical Corp (OM) Long-Term Debt to Capital Coefficient

Corporate emblem and logo of outsetmedical.com (OM)

The price trend reflected below complements the long-term liability data for Outset Medical, Inc. (OM), which stands at 1.12. High-margin replacement modules ensure a steady cash flow, creating strong user lock-in to the equipment. The business relies on the supply of compact dialysis units for both clinical and private use. The innovative nature of the Tablo system guarantees sustainable demand for home blood purification.

outsetmedical.com (OM): Long-Term Debt to Equity from 07/04/2022 to 10/29/2026
Original product of Outset Medical, Inc.

Stable cash flow from the sale of consumables for the Tablo system allows Outset Medical, Inc. (OM) to effectively manage its debt load. By analyzing the long-term debt-to-equity structure, an investor assesses the ratio of liabilities exceeding one year to equity, which determines the issuer's financial stability and the balance between the asset's risk profile and return potential across different market cycles.

Key competitors

Long-Term Liabilities to Capital DexCom Inc DXCM|Long-Term Debt to Equity Penumbra Corp (PEN)|NOVT (Novanta Photonics) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital HAE (Haemonetics Corporation)|Long-Term Debt to Capital inspiresleep.com INSP|PRCT - Long-Term Debt to Equity|Long-Term Liabilities to Equity CNMD|PLSE: Long-Term Debt to Capital|Long-Term Liabilities to Capital InMode MD (INMD)|Long-Term Debt to Equity Ratio PMI|Long-Term Debt to Capital surmodics.com|Long-Term Debt to Equity Ratio SENS (Eversense)|Long-Term Loans to Capital Ratio NPCE|Long-Term Debt to Capital TCMD (Tactile Medical)|Ratio of Long-Term Indebtedness to Capital SANUWAVE Health Inc (SNWV)|Electromed Inc - Long-Term Debt to Capital|lensar.com (LNSR) - Long-Term Debt to Equity Ratio|RCEL (AVITA Medical) - Long-Term Debt to Equity Ratio|Profound Medical - Long-Term Debt to Capital Coefficient|Long-Term Debt to Equity Baird Medical Investment Holdings|Long-Term Debt to Equity Ratio EDAP Medical (EDAP)|Long-Term Debt to Capital APYX|ICCM - Long-Term Liabilities to Capital|Long-Term Debt to Capital LUNG (Pulmonx)|TELA: Long-Term Debt to Capital Ratio|CytoSorbents Corp. - Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital Sensus SRTS|ZYXI: Long-Term Debt to Capital|Long-Term Debt to Equity Ratio electroCore|RBOT (Vicarious Surgical Inc) - Long-Term Debt to Capital|Long-Term Debt to Capital Inspira Technologies Oxy B.H.N. Ltd|Long-Term Debt to Equity SeaStar Medical Holding Corp (ICU)|Long-Term Debt to Equity IRIX (iridex.com)|Intelligent Bio Solutions Inc. - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Coefficient XAIR|Profusa - Long-Term Debt to Capital|Long-Term Liabilities to Capital STRATA Skin Sciences|GlucoTrack (GCTK) - Long-Term Debt to Equity|Long-Term Indebtedness to Equity NanoVibronix Inc. NAOV|Long-Term Debt to Equity Ratio VERO|Long-Term Debt to Capital nuwellis.com|Long-Term Debt to Capital AEMD|Ratio of Long-Term Indebtedness to Capital asensus.com|Long-Term Debt to Equity Avinger, Inc AVGR|BSGM (BioSig Technologies Inc.) - Long-Term Liabilities to Equity|CUTR - Long-Term Debt to Equity|knowlabs.co (KNW) - Long-Term Debt to Equity Ratio|NARI: Long-Term Debt to Capital|Long-Term Liabilities to Capital Nevro Corp (NVRO)|Long-Term Debt to Equity ReShape Lifesciences, Inc.|Long-Term Debt to Capital Ratio SILK (Silk Road Medical Inc)